NEW YORK (360Dx) – Chembio Diagnostics today said that the Brazilian health regulatory agency Agência Nacional de Vigilância Sanitária (ANVISA) approved the commercial use of the firm's DPP Micro Reader in that country, in collaboration with Bio-Manguinhos.

Chembio noted that because of the approval, its DPP Zika System, which includes a Zika IgM/IgG assay along with the micro reader, is also cleared for commercial use in Brazil.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Jun
05

This webinar will discuss how Sanofi used literature mining to annotate the association of human leukocyte antigen (HLA) alleles with diseases and drug hypersensitivity as part of a multiple sclerosis (MS) biomarker discovery project.

Jun
19

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.